DOI QR코드

DOI QR Code

A Case Report of Surgical Site Infection after Breast Cancer Surgery that Improved with Taglisodog-eum Treatment Alone

탁리소독음 단독치료로 호전된 유방암 수술부위감염 1례

  • Sung Soo Yoon (Integrative Oncology Center, Seon Woon Korean Medical Hospital) ;
  • Su-jeong Ha (Integrative Oncology Center, Seon Woon Korean Medical Hospital) ;
  • Moon Soo Jeong (Integrative Oncology Center, Seon Woon Korean Medical Hospital) ;
  • Seong Woo Yoon (Department of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong)
  • 윤성수 (선운한방병원 통합암센터) ;
  • 하수정 (선운한방병원 통합암센터) ;
  • 정문수 (선운한방병원 통합암센터) ;
  • 윤성우 (강동경희대학교병원 한방내과)
  • Received : 2023.10.13
  • Accepted : 2023.12.03
  • Published : 2023.12.31

Abstract

Objectives: With antibiotic resistance one of the biggest threats to global health, we report a case of surgical site infection (SSI) after breast cancer surgery that improved only with the treatment of Taglisodog-eum (托裏消毒飮), Korean herbal medicine, without the use of antibiotics. Methods: The patient diagnosed with ductal carcinoma in situ of left breast underwent nipple areola skin sparing mastectomy and reconstruction using deep inferior epigastric perforator flap. About a month later, superficial SSI occurred at the incision site of breast cancer surgery with general weakness, and Taglisodog-eum treatment was started. To evaluate the effectiveness of the treatment, we compared the infection site conditions before and after treatment. Results: About three weeks after taking Taglisodog-eum, the SSI improved along with the improvement of general weakness. Conclusions: This study shows that Taglisodog-eum may be effective for SSI after breast cancer surgery, and the potential for alternatives to reduce antibiotic use and antibiotic resistance.

Keywords

References

  1. American Cancer Society. Cancer Facts & Figures 2021. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf 
  2. Kang MJ, Jung KW, Bang SH, Choi SH, Park EH, Yun EH, Kim HJ, Kong HJ, Im JS, Seo HG; Community of Population-Based Regional Cancer Registries. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020. Cancer Res Treat. 55(2):385-399. 2023  https://doi.org/10.4143/crt.2023.447
  3. NCCN clinical practice guidelines in oncology (NCCN guidelines) breast cancer. Version 4. 2023. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf 
  4. Al-Hilli Z, Wilkerson A. Breast Surgery: Management of Postoperative Complications Following Operations for Breast Cancer. Surg Clin North Am. 101(5):845-863. 2021  https://doi.org/10.1016/j.suc.2021.06.014
  5. Surgical site infection event (SSI). National Healthcare Safety Network. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf 
  6. Jorgensen MG, Gozeri E, Petersen TG, Sorensen JA. Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study. Clin Breast Cancer. 23(5):e296-e304.e2. 2023  https://doi.org/10.1016/j.clbc.2023.03.016
  7. Li J, Feng S, Liu X, et al. Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria. Front Pharmacol. 13:837907. 2022 
  8. Lee H, Kang B, Hong M, Lee HL, Choi JY, Lee JA. Eunkyosan for the common cold: A PRISMA-compliment systematic review of randomised, controlled trials. Medicine (Baltimore). 99(31):e21415. 2020 
  9. Zhang S, Wang Z, Xu G. Effect of Amoxicillin and Clavulanate Potassium Combined with Bazhengsan on Pediatric Urinary Tract Infection. Evid Based Complement Alternat Med. 2021:4575503. 2021 
  10. US Department of Health and Human Services; National Institutes of Health; National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf 
  11. Seidelman JL, Mantyh CR, Anderson DJ. Surgical Site Infection Prevention: A Review. JAMA. 329(3):244-252. 2023  https://doi.org/10.1001/jama.2022.24075
  12. Bolton L. Surgical Site Infection in Cancer Patients. Wounds. 33(10):260-262. 2021  https://doi.org/10.25270/wnds/2021.260262
  13. Lee JY, Kim EH, Yoon JH, Eo W, Yoon SW. Traditional Herbal Medicine, Sipjeondaebo-Tang, for Cancer-Related Fatigue: A Randomized, Placebo-Controlled, Preliminary Study. Integr Cancer Ther. 20:15347354211040830. 2021 
  14. 한국한의학연구원. 한의학고전DB. Available from: https://mediclassics.kr/books/8/volume/15#content_1045 
  15. 이형재, 권강범, 신병철, 김은경, 한미정, 송미영, 이영래, 박병현, 류도곤. 남성호르몬 비의존형 전립선 암세포에서 托裏消毒飮 추출물의 세포고사 유도 효과. 동의생리병리학회지. 20(4):861-5. 2006 
  16. 박형권, 권강범, 김은경, 한미정, 송미영, 이영래, 박병현, 류도곤. 托裏消毒飮의 PC-3 세포에 대한 세포고사 유도 효과 및 기전 연구. 동의생리병리학회지. 20(4):946-50. 2006 
  17. 梁起鎬. 托裏消毒飮의 抗腫瘍 效果 및 免疫調節反應에 關한 硏究. 大韓韓醫學方劑學會誌. 5(1):147-68. 1997 
  18. Hwang JS, Kim JE, Kim HT, Yu YB, Im SH. Topical application of Taglisodog-eum inhibits the development of experimental atopic dermatitis. J Ethnopharmacol. 30;145(2):536-546. 2013 https://doi.org/10.1016/j.jep.2012.11.026